46.46.Z - Wholesale trade of pharmaceutical and medical products
10.86.Z - Production of homogenized food products and diet food
10.89.Z - Production of other food products, not elsewhere classified
21.10.Z - Manufacture of basic pharmaceutical products
21.20.Z - Manufacture of pharmaceutical preparations and other pharmaceutical products
46.18.Z - Activity of agents involved in wholesale trade of other specified goods
46.19.Z - Activity of agents involved in wholesale trade of non-specialized goods
46.45.Z - Wholesale trade of perfumes and cosmetics
46.75.Z - Wholesale trade
72.19.Z - Scientific research and development activities
2021 | 2022 | 2023 | ||
---|---|---|---|---|
K PLN | K PLN | K PLN | % | |
Profit (loss) on sale | -4,8 | -5,8 | -5,6 | 3,2 |
Gross profit (loss) | 4,2 | -5,8 | -5,6 | 3,2 |
EBITDA | -4,8 | -5,8 | -5,6 | 3,2 |
Short time liabilities | 1,3 | 1,2 | 1,7 | 49,7 |
Other operating costs | 0 | 0 | 0 | 0 |
Equity capital | 41,3 | 35,5 | 29,9 | -15,8 |
Operating profit (EBIT) | -4,8 | -5,8 | -5,6 | 3,2 |
Assets | 42,6 | 36,7 | 31,7 | -13,7 |
Net profit (loss) | 3,2 | -5,8 | -5,6 | 3,2 |
Cash | 13,7 | 25,3 | 18,7 | -25,9 |
Net income from sale | 5,6 | 0 | 0 | 0 |
Liabilities and provisions for liabilities | 1,3 | 1,2 | 1,7 | 49,7 |
Working assets | 42,6 | 36,7 | 31,7 | -13,7 |
Other income costs | 0 | 0 | 0 | -75 |
Depreciation | 0 | 0 | 0 | 0 |
% | % | % | p.p. | |
Profitability of capital | 7,7 | -16,3 | -18,7 | -2,4 |
Equity capital to total assets | 97,1 | 96,8 | 94,5 | -2,3 |
Gross profit margin | 74,9 | |||
EBITDA Margin | -85,3 | |||
Days | Days | Days | Days | |
Short term commitment turnover cycle | 82 | 2 147 483 648 | 2 147 483 648 | 0 |
Current financial liquidity indicator | 34.02388381958008 | 31.508625030517578 | 18.16032600402832 | -13,3 |
Net dept to EBITDA | 2.875051736831665 | 4.367227077484131 | 3.3415310382843018 | -1,1 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane